ESR1 and breast cancer: Furthermore, circulating miR-200c was recently shown to distinguish relapsed from non-relapsed patients with early breast cancer and, combined with lymph node infiltration, estrogen receptor status, and tumor grade, even to predict occurrence of late relapse [12].